Toho Holdings Co (FRA:TON) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TON Toho Holdings Co Ltd FRA:TON
34 GF Score
Price €21.40
GF Value €26.17
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Toho Holdings Co Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:TON
34GF Score
Toho Holdings Co Ltd FRA:TON
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Toho Holdings Co (FRA:TON) Overvalued in 2026?

Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued. The current stock price of €21.40 is trading 18.2% below its estimated GF Value™ of €26.17. GuruFocus considers Toho Holdings Co to be Modestly Undervalued.

Key valuation signals for FRA:TON:

  • Interest Received:
  • GF Value™: €26.17 vs. price of €21.40 (18.2% below fair value)
  • GF Score™: 34/100 with 3 warning signs

No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Toho Holdings Co Business Description

Other Exchanges 8129:Japan
Address 4-43-11 Daizawa, Setagaya-ku, Tokyo, JPN, 155-8655
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
34GF Score

Get the complete analysis for FRA:TON

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.40
Price
€26.17
GF Value